4-(Aminoalkylamino)-3-benzimidazole-quinolinones as potent CHK-1 inhibitors.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2006-06-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BMCL.2006.03.059PMID 16603354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors.

  2006cited by this paper
• Structure-based design of novel Chk1 inhibitors: insights into hydrogen bonding and protein-ligand affinity.

  2005cited by this paper
• 1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyanopyrazin-2-yl)ureas [correction of cyanopyrazi] as potent and selective inhibitors of Chk1 kinase: synthesis, preliminary SAR, and biological activities.

  2005cited by this paper
• Implications of p53 in growth arrest and apoptosis on combined treatment of human Mammary epithelial cells with topotecan and UCN-01.

  2004cited by this paper
• Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging Agents*

  2003cited by this paper
• Drug discovery targeting Chk1 and Chk2 kinases.

  2003cited by this paper
• Structural Basis for Chk1 Inhibition by UCN-01*

  2002cited by this paper
• Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints

  2002cited by this paper
• Structural basis for Chk1 inhibition by UCN-01.

  2002cited by this paper
• Targeting serine/threonine protein kinase B/Akt and cell-cycle checkpoint kinases for treating cancer.

  2002cited by this paper
• Chapter 12. Intracellular signaling targets for cancer chemosensitization

  2002cited by this paper
• A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01.

  2002cited by this paper
• Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells

  2001cited by this paper
• Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms.

  2001cited by this paper
• The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1.

  2000cited by this paper
• The Chk1 Protein Kinase and the Cdc25C Regulatory Pathways Are Targets of the Anticancer Agent UCN-01*

  2000cited by this paper
• UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.

  1996cited by this paper
• Enhancement of cisplatin-induced cytotoxicity by 7-hydroxystaurosporine (UCN-01), a new G2-checkpoint inhibitor.

  1996cited by this paper
• UCN-01, a selective inhibitor of protein kinase C from Streptomyces.

  1987cited by this paper
• Pyrazolo[5,1-b]quinazolin-9-ones: a new series of antiallergic agents.

  1981cited by this paper
• THE CHEMISTRY OF 2H‐3,1‐BENZOXAZINE‐2,4(1H)DIONE (ISATOIC ANHYDRIDES) PART 1, THE SYNTHESIS OF N‐SUBSTITUTED 2H‐3,1‐BENZOXAZINE‐2,4(1H)DIONES

  1975cited by this paper

• A Hanks-type bacterial kinase, PknS, directly phosphorylates the alternative sigma factor EcfK to promote resistance to protist predation.

  2026cites this paper
• CO2-Driven C(sp2)-H Lactamization to 2-Quinolinones.

  2026cites this paper
• Topoisomerase II-targeting anticancer clinical candidates and drugs: A critical analysis, unravelling molecular medicinal insights and promising research roadmap.

  2025cites this paper
• Light-induced isomerization of quinoline-N-oxide derivatives through Zn-catalysis: a photochemical approach for synthesizing 2-quinolinone derivatives

  2024cites this paper
• Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights.

  2024cites this paper
• 4-oxoquinoline-3-carboxamide acyclonucleoside phosphonates hybrids: human MCF-7 breast cancer cell death induction by oxidative stress-promoting and in silico ADMET studies

  2022cites this paper
• Oxidation of N-Alkyl(iso)quinolinium Salts Over TEMPO@Metal-Organic Framework Heterogeneous Photocatalyst.

  2022cites this paper
• Efficient Hit-to-Lead Searching of Kinase Inhibitor Chemical Space via Computational Fragment Merging

  2021influential citation
• Ring expansion and ring opening of 3-halooxindoles with N-alkoxycarbonyl-O-tosylhydroxylamines for divergent access to 4-aminoquinolin-2-ones and N-Cbz-N’-arylureas

  2021cites this paper
• Recent Advances in One-Pot Modular Synthesis of 2-Quinolones

  2020cites this paper
• Synthesis and biological evaluation of chalcone derivatives of 1,2,4-thiadiazol-benzo[d]imidazol-2-yl)quinolin-2(1H)-one as anticancer agents

  2020cites this paper
• Versatile mechanisms of 2-substituted benzimidazoles in targeted cancer therapy

  2020cites this paper
• Synthesis, crystal structure, spectroscopic, thermal properties and DFT calculation of a novel ethyl 2-(2-(thiazol-4-yl)-1H-benzimidazol-1-yl)acetate

  2020cites this paper
• Recent Progress of benzimidazole hybrids for anticancer potential.

  2019cites this paper
• Synergistic Effect over Sub-nm Pt Nanocluster@MOFs Significantly Boosts Photo-oxidation of N-alkyl(iso)quinolinium Salts

  2019cites this paper
• Recent advances in the synthetic and medicinal perspective of quinolones: A review.

  2019cites this paper
• Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro

  2018cites this paper
• Gold-catalyzed post-Ugi alkyne hydroarylation for the synthesis of 2-quinolones

  2018cites this paper
• Synthesis of benzoquinoline derivatives from formyl naphthylamines via Friedländer annulation under metal-free conditions

  2018cites this paper
• Palladium Catalyzed Direct Acylation of Iodo‐Acetanilides/Iodo‐Phenyl Acetates: Domino One‐Pot Synthesis of 2‐Quinolinones

  2018cites this paper
• Imidazoles as potential anticancer agents.

  2017cites this paper
• Limited nucleotide pools restrict Epstein–Barr virus-mediated B-cell immortalization

  2017cites this paper
• Synthesis of Constrained Heterocycles Employing Two Post-Ugi Cyclization Methods for Rapid Library Generation with In Cellulo Activity.

  2017cites this paper
• Direct amino-halogenation and aziridination of the 2-quinolone framework by sequential treatment of 3-nitro-2-quinolone with amine and N-halosuccinimide

  2017cites this paper
• Visible-Light-Mediated Aerobic Oxidation of N-Alkylpyridinium Salts under Organic Photocatalysis.

  2017cites this paper
• Quinolones in the Search for New Anticancer Agents.

  2016cites this paper
• Synthesis of Biheterocycles Based on Quinolinone, Chromone, and Coumarin Scaffolds by Palladium-Catalyzed Decarboxylative Couplings.

  2016cites this paper
• Combining docking-based comparative intermolecular contacts analysis and k-nearest neighbor correlation for the discovery of new check point kinase 1 inhibitors

  2015cites this paper
• Practical route to 2-quinolinones via a Pd-catalyzed C-H bond activation/C-C bond formation/cyclization cascade reaction.

  2015cites this paper
• Nuclear magnetic resonance, vibrational spectroscopic studies, physico-chemical properties and computational calculations on (nitrophenyl) octahydroquinolindiones by DFT method.

  2015cites this paper
• A general Pd/Cu-catalyzed C-H heteroarylation of 3-bromoquinolin-2(1H)-ones.

  2014cites this paper
• Docking-based 3D-QSAR study of pyridyl aminothiazole derivatives as checkpoint kinase 1 inhibitors

  2014cites this paper
• Differential response of normal and malignant urothelial cells to CHK1 and ATM inhibitors

  2014cites this paper
• Palladium-catalyzed carbonylative [3+2+1] annulation of N-aryl-pyridine-2-amines with internal alkynes by C-H activation: facile synthesis of 2-quinolinones.

  2014cites this paper
• Design, synthesis and biological evaluation of thienopyridinones as Chk1 inhibitors.

  2014cites this paper
• Synthesis, characterization and tyrosinase inhibitory properties of benzimidazole derivatives

  2014cites this paper
• Structural analysis of the human fibroblast growth factor receptor 4 kinase.

  2014cites this paper
• The N550K/H mutations in FGFR2 confer differential resistance to PD173074, dovitinib, and ponatinib ATP-competitive inhibitors.

  2013cites this paper
• The N 550 K / H Mutations in FGFR 2 Confer Differential Resistance to PD 173074 , Dovitinib , and Ponatinib ATP-Competitive Inhibitors 1

  2013cites this paper
• Synthesis, Characterisation and Antimicrobial studies of complexes of metal ions with 4-{(E)-(1-(1H-benzo(d)imidazol-2-yl)ethylidene)amino}-3- methyl-1H-1, 2, 4-triazole-5(4H)-thione and related ligand.

  2013cites this paper
• Novel research strategies of benzimidazole derivatives: a review.

  2013cites this paper
• Molecular docking and 3D-QSAR studies on checkpoint kinase 1 inhibitors

  2013cites this paper
• Identification of potent Yes1 kinase inhibitors using a library screening approach.

  2013cites this paper
• Synthesis of 2(1H)-quinolinones via Pd-catalyzed oxidative cyclocarbonylation of 2-vinylanilines.

  2013cites this paper
• The therapeutic journey of benzimidazoles: a review.

  2012cites this paper
• Discovery of Novel Checkpoint Kinase 1 Inhibitors by Virtual Screening Based on Multiple Crystal Structures

  2011cites this paper
• Design, synthesis, and testing of an 6-O-linked series of benzimidazole based inhibitors of CDK5/p25.

  2011cites this paper
• Synthesis of selenophene derivatives as novel CHK1 inhibitors.

  2010cites this paper
• Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors

  2010cites this paper
• 3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA

  2010cites this paper
• Checkpointkinaseinhibitors:a reviewofthepatentliterature

  2009cites this paper
• Checkpoint kinase inhibitors: a review of the patent literature

  2009cites this paper
• Molecular Docking and 3D QSAR Studies of Chk2 Inhibitors

  2009cites this paper
• Design, structure-activity relationships and in vivo characterization of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones: a novel class of receptor tyrosine kinase inhibitors.

  2009cites this paper
• Pharmacophore modeling and virtual screening studies of checkpoint kinase 1 inhibitors.

  2009cites this paper
• Vilsmeier reaction of enaminones: efficient synthesis of halogenated pyridin-2(1H)-ones.

  2008cites this paper
• Cell cycle inhibitors in cancer: current status and future directions

  2008cites this paper
• The Mammalian DNA Replication Elongation Checkpoint: Implication of Chk1 and Relationship with Origin Firing as Determined by Single DNA Molecule and Single Cell Analyses

  2007cites this paper
• Identification of novel, selective and potent Chk2 inhibitors.

  2007cites this paper
• Novel Inhibitors of Checkpoint Kinase 1

  2007cites this paper
• Synthesis and biological evaluation of 4'-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors.

  2007cites this paper
• Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors.

  2007cites this paper
• Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors.

  2007cites this paper
• Discovery of 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-benzonitriles and 4'-(1,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-pyridine-2'-carbonitriles as potent checkpoint kinase 1 (Chk1) inhibitors.

  2007cites this paper
• The Intra-S-Phase Checkpoint Affects both DNA Replication Initiation and Elongation: Single-Cell and -DNA Fiber Analyses

  2007influential citation
• Inhibitors of checkpoint kinases: from discovery to the clinic.

  2007cites this paper
• CHIR-124, a Novel Potent Inhibitor of Chk1, Potentiates the Cytotoxicity of Topoisomerase I Poisons In vitro and In vivo

  2007cites this paper
• 4‐(Aminoalkylamino)‐3‐benzimidazole‐quinolinones as Potent CHK‐1 Inhibitors.

  2006cites this paper
• Development of 6-substituted indolylquinolinones as potent Chek1 kinase inhibitors.

  2006cites this paper